Skip to main content
. 2024 Oct 12;25(20):10980. doi: 10.3390/ijms252010980

Table 1.

Age, anthropometric, and clinical data of CTR and RA groups.

CTR
n = 50
RA
n = 56
p
Age (years) 56.5 (49.8–65.3) 62.5 (54.5–6.0) 0.116
Female 46 (92.0) 52 (92.9) 1.000
BMI (Kg/m2) 28.2 (25.9–31.3) 28.6 (25.4–31.7) 0.651
WC (cm) 96.0 (91.0–102.5) 96.0 (89.3–106.0) 0.761
Obesity 16 (32.0) 21 (37.5) 0.684
Dyslipidemia 22 (44.0) 18 (32.1) 0.233
Statin use 10 (20.0) 10 (17.9) 0.808
Post-menopausal 34 (73.9) 45 (86.5) 0.132
HRT 5 (10.9) 10 (19.2) 0.277
HC 3 (6.5) 0 (0.0) 0.100
Physical activity ≥ 150 min/wk 10 (20.0) 10 (17.9) 0.808
DAS28 4.15 (3.28–5.03)
Disease remission 7 (12.5)
Low-activity disease 6 (10.7)
Moderate-activity disease 31 (55.4)
High-activity disease 12 (21.4)

RA: rheumatoid arthritis group; CTR: control group; BMI: body mass index; DAS28: Disease Activity Score with 28-joint counts; WC: waist circumference; HRT: hormonal replacement therapy; HC: hormonal contraceptive. Results are expressed as median and interquartile intervals (25% and 75%) or n (%). Data were compared using the Mann–Whitney test and Fisher’s exact test for categorical variables, always as two-sided analyses.